Could psychedelics open new doors in medicine, or are patients being asked to trust the promise before the proof is in?

Sign up for weekly webinars: Weekly Webinars - Independent Medical Alliance

This episode of IMA’s Weekly Show aired Wednesday, April 29, 2026.

Dr. Ryan Cole, IMA Head of Medical & Scientific Affairs, sits down with Dr. Molly Rutherford, IMA Senior Fellow in Family Medicine and Addiction Medicine, to separate hope from hype around psychedelic-assisted therapies.

They discuss:

• Why interest in psychedelic-assisted therapies is growing now

• What the current science does and does not show

• Why these substances have been difficult to study

• The risks of moving too quickly toward unproven treatments

• What responsible progress could look like for patients, families, and physicians

The bottom line: when a treatment changes lives, it deserves to be studied carefully, not rushed blindly.

First aired 29th April 2026

Also:

• Donate: https://imahealth.org/donate/

• Follow: https://imahealth.org/contact/

• Webinar: https://imahealth.org/category/weekly-webinars/

• Treatment: https://imahealth.org/treatment-protocols/

• Medical Disclaimer: https://imahealth.org/about/terms-and-conditions/

About IMA (Formerly FLCCC Alliance)

The Independent Medical Alliance™ is a nonprofit, 501(c)(3) organization and coalition of physicians, nurses, and healthcare professionals united by a mission to restore trust and transparency in healthcare. The organization’s mission is one driven by Honest Medicine™ that prioritizes patients above profits and emphasizes long-term wellness and disease prevention through empowerment of both physicians and their patients. With a focus on evidence-based medicine, informed consent, and systemic reform, IMA is driving a movement to create a more compassionate and effective healthcare system.

For more information about the Independent Medical Alliance, visit www.IMAhealth.org